PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
21-Oct-2019 Theravance Biopharma and Mylan to Present New Data on YUPELRI® (revefenacin) at the 2019 CHEST Annual Meeting Mylan N.V.; Theravance Biopharma, Inc.
21-Oct-2019 FDA approves new breakthrough therapy for cystic fibrosis U.S. Food and Drug Administration
21-Oct-2019 Lilly Declares Fourth-Quarter 2019 Dividend Eli Lilly and Company
21-Oct-2019 CO.DON AG: co.don Aktiengesellschaft decides to increase share capital through rights issue with subscription rights of existing shareholders CO.DON AG
21-Oct-2019 Centrient Pharmaceuticals Initiates a Second Patent Litigation in India Against Dalas Biotech Limited Centrient Pharmaceuticals
21-Oct-2019 Exclusive Interview with Cedric Gysel Johnson and Johnson’s Cedric Gysel for Pre-Filled Syringe and Injectable Drug Devices 2020 SMi Group
21-Oct-2019 B. Riley FBR to Host NASH Symposium in San Francisco on October 24, 2019 B. Riley FBR, a B. Riley Financial company
21-Oct-2019 Interactive workshops announced for SMi’s 14th Annual Parallel Trade Conference 2020 SMi Group
21-Oct-2019 Patients with ultra-rare bone marrow disease set to benefit from £1.15m grant from LifeArc and The Aplastic Anaemia Trust LifeArc
21-Oct-2019 Finalists revealed for CPhI Worldwide’s eagerly anticipated 2019 Awards CPhI
21-Oct-2019 ‘FDA should withdraw ANDAs’, and ‘new technologies could bring massive improvements in efficiency’ if implemented correctly CPhI
21-Oct-2019 Regenerative Medicines - A More Effective and Result Oriented Way to treat chronic Diseases for Long Term Range Global Regenerative Medicines
21-Oct-2019 ISCT forms cell and gene therapy sector-wide coalition to combat the rise of unproven commercial cell banking services the International Society for Cell and Gene Therapy
21-Oct-2019 New subcutaneous formulation of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) shows positive Phase 1 results for the treatment of IBD in data presented at UEG Week Barcelona 2019 Celltrion Healthcare
21-Oct-2019 Retrospective Real-World Comparative Analysis Highlights Safety of Vedolizumab and Anti-TNFα Therapies in Biologic-Naïve Patients with Ulcerative Colitis or Crohn’s Disease Takeda Pharmaceutical Company Limited
21-Oct-2019 Retrospective Real-World Comparative Analysis Highlights Safety of Vedolizumab and Anti-TNFα Therapies in Biologic-Naïve Patients with Ulcerative Colitis or Crohn’s Disease Takeda Pharmaceutical Company Limited
21-Oct-2019 Moberg Pharma and DongKoo sign agreement for MOB-015 in the Republic of Korea Moberg Pharma AB
21-Oct-2019 BD Launches BD Intevia™ 1mL Two-step Disposable Autoinjector – A Robust Platform Device Combining Autoinjector and Pre-Fillable Syringe in One Integrated System BD
21-Oct-2019 Vamorolone Designated Promising Innovative Medicine (PIM) for Treatment of Duchenne Muscular Dystrophy by the UK MHRA Santhera Pharmaceuticals
21-Oct-2019 Bavarian Nordic Announces a Transformative Acquisition of Two Established Commercial Vaccines from GlaxoSmithKline Bavarian Nordic A/S